JP2022521173A5 - - Google Patents
Info
- Publication number
- JP2022521173A5 JP2022521173A5 JP2021547154A JP2021547154A JP2022521173A5 JP 2022521173 A5 JP2022521173 A5 JP 2022521173A5 JP 2021547154 A JP2021547154 A JP 2021547154A JP 2021547154 A JP2021547154 A JP 2021547154A JP 2022521173 A5 JP2022521173 A5 JP 2022521173A5
- Authority
- JP
- Japan
- Prior art keywords
- erdafitinib
- cancer
- specifically
- daily
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025162216A JP2026016402A (ja) | 2019-02-12 | 2025-09-29 | 癌治療 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19156806.2 | 2019-02-12 | ||
| EP19156806 | 2019-02-12 | ||
| EP19176575 | 2019-05-24 | ||
| EP19176575.9 | 2019-05-24 | ||
| PCT/EP2020/053490 WO2020165181A1 (en) | 2019-02-12 | 2020-02-11 | Cancer treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025162216A Division JP2026016402A (ja) | 2019-02-12 | 2025-09-29 | 癌治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521173A JP2022521173A (ja) | 2022-04-06 |
| JP2022521173A5 true JP2022521173A5 (enExample) | 2023-02-21 |
Family
ID=69467563
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547154A Withdrawn JP2022521173A (ja) | 2019-02-12 | 2020-02-11 | 癌治療 |
| JP2025162216A Pending JP2026016402A (ja) | 2019-02-12 | 2025-09-29 | 癌治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025162216A Pending JP2026016402A (ja) | 2019-02-12 | 2025-09-29 | 癌治療 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20220168298A1 (enExample) |
| EP (1) | EP3923942A1 (enExample) |
| JP (2) | JP2022521173A (enExample) |
| KR (1) | KR20210126654A (enExample) |
| CN (1) | CN113423402A (enExample) |
| AU (1) | AU2020223467B2 (enExample) |
| BR (1) | BR112021015686A2 (enExample) |
| CA (1) | CA3126959A1 (enExample) |
| IL (1) | IL285466A (enExample) |
| JO (1) | JOP20210216A1 (enExample) |
| MA (1) | MA54932A (enExample) |
| MX (1) | MX2021009670A (enExample) |
| PH (1) | PH12021551949A1 (enExample) |
| SG (1) | SG11202107850VA (enExample) |
| TW (1) | TWI863962B (enExample) |
| WO (1) | WO2020165181A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023553533A (ja) * | 2020-12-11 | 2023-12-21 | エラスカ，インク． | 癌の処置のための併用療法 |
| CN117083283A (zh) * | 2020-12-11 | 2023-11-17 | 医睿世康药业研发公司 | 用于癌症治疗的联合疗法 |
| CN112957368A (zh) * | 2021-04-02 | 2021-06-15 | 南昌大学 | 一种司维拉姆的新用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102470456B1 (ko) * | 2014-09-26 | 2022-11-23 | 얀센 파마슈티카 엔.브이. | Fgfr 억제제를 사용한 치료에 반응할 암 환자를 확인하는 데 있어서 fgfr 돌연변이 유전자 패널의 사용 |
| TWI719960B (zh) * | 2015-02-10 | 2021-03-01 | 英商阿斯迪克治療公司 | 新穎組成物 |
| US10208024B2 (en) * | 2015-10-23 | 2019-02-19 | Array Biopharma Inc. | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases |
| HUE062453T2 (hu) * | 2017-02-06 | 2023-11-28 | Janssen Pharmaceutica Nv | Rákbetegség kezelése |
| TWI798199B (zh) * | 2017-02-06 | 2023-04-11 | 比利時商健生藥品公司 | 癌症治療 |
| JOP20190280A1 (ar) * | 2017-06-02 | 2019-12-02 | Janssen Pharmaceutica Nv | مثبطات fgfr2 لعلاج سرطان الأوعية الصفراوية |
-
2020
- 2020-02-11 EP EP20703477.8A patent/EP3923942A1/en active Pending
- 2020-02-11 SG SG11202107850VA patent/SG11202107850VA/en unknown
- 2020-02-11 CN CN202080013784.5A patent/CN113423402A/zh active Pending
- 2020-02-11 PH PH1/2021/551949A patent/PH12021551949A1/en unknown
- 2020-02-11 AU AU2020223467A patent/AU2020223467B2/en active Active
- 2020-02-11 KR KR1020217028671A patent/KR20210126654A/ko not_active Ceased
- 2020-02-11 MA MA054932A patent/MA54932A/fr unknown
- 2020-02-11 BR BR112021015686-0A patent/BR112021015686A2/pt unknown
- 2020-02-11 US US17/430,025 patent/US20220168298A1/en active Pending
- 2020-02-11 WO PCT/EP2020/053490 patent/WO2020165181A1/en not_active Ceased
- 2020-02-11 JP JP2021547154A patent/JP2022521173A/ja not_active Withdrawn
- 2020-02-11 JO JOP/2021/0216A patent/JOP20210216A1/ar unknown
- 2020-02-11 CA CA3126959A patent/CA3126959A1/en active Pending
- 2020-02-11 MX MX2021009670A patent/MX2021009670A/es unknown
- 2020-02-12 TW TW109104389A patent/TWI863962B/zh active
-
2021
- 2021-08-09 IL IL285466A patent/IL285466A/en unknown
-
2025
- 2025-09-29 JP JP2025162216A patent/JP2026016402A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018203205B2 (en) | Use of ferric citrate in the treatment of chronic kidney disease patients | |
| JP2020505425A5 (enExample) | ||
| EP4110326B1 (en) | Combination comprising alpelisib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid | |
| JP2022521173A5 (enExample) | ||
| CN107519159A (zh) | 复方组合物 | |
| CN110013478A (zh) | 用于抗肿瘤试剂施用的方法 | |
| KR102766876B1 (ko) | 타우로데옥시콜린산 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 코로나바이러스감염증-19(covid-19) 치료용 조성물 | |
| JP2024502446A5 (enExample) | ||
| JP2024539476A5 (enExample) | ||
| JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び／又は敗血症の予防若しくは治療のための組成物 | |
| TW201521742A (zh) | 具降低毒性之庫司替森（ｃｕｓｔｉｒｓｅｎ）療法 | |
| WO2024041633A1 (zh) | 一种稠环嘧啶类化合物的用途 | |
| JP2024531799A5 (enExample) | ||
| CN113876777A (zh) | 尼达尼布治疗异常新生血管形成骨关节疾病的方法 | |
| CN109106720B (zh) | 西达本胺与依西美坦在制备用于治疗乳腺癌的联合用药物中的用途及联合用药物 | |
| CN104906501A (zh) | 治疗银屑病的中药组分组合物 | |
| WO2018201920A1 (zh) | 龙虎人丹在制备预防和/或治疗肝纤维化药物中的应用 | |
| TWI922738B (zh) | 化合物或其藥劑學上可接受的鹽用於製造實性瘤治療用醫藥組成物之用途 | |
| JP2022527189A5 (enExample) | ||
| CN115154448B (zh) | 一种治疗不宁腿综合征的药物及其制备方法和应用 | |
| JP2003095981A (ja) | 医薬組成物 | |
| CN114712427B (zh) | 一种桃树根药物的应用 | |
| CN114949147B (zh) | 一种治疗慢性咽炎的中药组合物，其制备方法和应用 | |
| JP2009263384A (ja) | Ｉ型アレルギー性疾患のアトピー性皮膚炎の症状を抑制するための内服薬 | |
| TWI599371B (zh) | 醫藥組合物用於製備治療檳榔使用失調之藥物上的用途 |